April 2020

Rucaparib is FDA approved in patients with a BRCA mutation and who have received 2 more prior lines of previous chemotherapy.

In a Pharmacy Times®Practice Pearls video series, experts discussed best practices in the management of AML.

Rural patients are in greatest need of such ancillary services as those provided by dietitians and social workers.

LGBTQ patients with cancer face specific barriers when seeking medical care, but pharmacists and other medical professionals can take specific steps to reduce care gaps.

This activity is supported by an educational grant from AstraZeneca.

Cannabis products can counter some negative aspects of chemotherapy.

The FDA does not usually require animalstudies for biosimilars; therefore, the process can move directly to pharmacokinetic and pharmacodynamic studies.

Compared with other breast cancer subtypes, TNBC is more likely to be diagnosed in younger women and is more likely to have metastases present at the time of diagnosis.

Importantly, when considering the useof small molecule inhibitors, potential drug interactions must be evaluated.

Check out these pre- and postimplementation checklists, which also help to justify the investment.

The industry has concentrated its efforts on developing new therapies with few or no competitors.

Medically integrated pharmacies with access to the EMR incorporate this information into the treatment plan.

Cases studies focused on medication reconcilliation for patients with breast cancer.

Oncology pharmacists can prevent errors that occur when a patient’s medications include prescription drugs, OTC medications, herbals, and dietary supplements.